SEI Investments’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.59M Buy
43,949
+8,220
+23% +$858K 0.01% 1304
2025
Q1
$4.17M Sell
35,729
-12,501
-26% -$1.46M 0.01% 1342
2024
Q4
$4.08M Sell
48,230
-131
-0.3% -$11.1K 0.01% 1389
2024
Q3
$4.35M Buy
48,361
+7,737
+19% +$695K 0.01% 1354
2024
Q2
$3.27M Buy
40,624
+4,970
+14% +$400K ﹤0.01% 1410
2024
Q1
$2.85M Buy
35,654
+2,697
+8% +$215K ﹤0.01% 1464
2023
Q4
$2.62M Sell
32,957
-28,178
-46% -$2.24M ﹤0.01% 1480
2023
Q3
$4.27M Sell
61,135
-123,132
-67% -$8.61M 0.01% 1240
2023
Q2
$13.2M Buy
184,267
+60,158
+48% +$4.32M 0.02% 726
2023
Q1
$7.66M Sell
124,109
-13,358
-10% -$824K 0.01% 986
2022
Q4
$10.6M Sell
137,467
-11,322
-8% -$873K 0.02% 707
2022
Q3
$6.64M Sell
148,789
-13,797
-8% -$616K 0.01% 947
2022
Q2
$6.23M Buy
162,586
+16,223
+11% +$621K 0.01% 990
2022
Q1
$6.06M Buy
146,363
+1,909
+1% +$79K 0.01% 1005
2021
Q4
$5.46M Sell
144,454
-1,338
-0.9% -$50.6K 0.01% 1089
2021
Q3
$4.81M Sell
145,792
-388
-0.3% -$12.8K 0.01% 1102
2021
Q2
$9.86M Buy
146,180
+2,010
+1% +$136K 0.02% 741
2021
Q1
$8.16M Buy
144,170
+33,649
+30% +$1.91M 0.02% 766
2020
Q4
$9M Buy
110,521
+29,098
+36% +$2.37M 0.02% 686
2020
Q3
$5.8M Buy
81,423
+28,796
+55% +$2.05M 0.02% 802
2020
Q2
$4.33M Sell
52,627
-1,088
-2% -$89.5K 0.01% 929
2020
Q1
$3.16M Buy
53,715
+21,432
+66% +$1.26M 0.01% 959
2019
Q4
$3.34M Buy
32,283
+9,535
+42% +$986K 0.01% 1104
2019
Q3
$460K Sell
22,748
-4,910
-18% -$99.3K ﹤0.01% 1931
2019
Q2
$712K Sell
27,658
-15,987
-37% -$412K ﹤0.01% 1720
2019
Q1
$621K Buy
+43,645
New +$621K ﹤0.01% 1777